Search - tctmd.com

Displaying 241 - 260 of 1124

Sort: Relevancy | Date

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Conference News ACC 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

Shelley Wood

April 11, 2022

News Conference News ACC 2022

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

Todd Neale

April 11, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Todd Neale

April 03, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

Todd Neale

March 22, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Caitlin E. Cox

January 31, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Advertisement

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Managing AF Patients Undergoing PCI—Some Lingering Questions

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

What’s Going to Be Hot at ACC 2022, In Person or Virtual

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

More Evidence Links Breast Arterial Calcification and CVD Risk

March 2022 News Roundup

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

January 2022 News Roundup

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content